KaloBios Says Martin Shkreli Terminated as CEOBy
Fellow board member Tony Chase also resigned on Thursday
Shkreli held more than 50 percent of shares as of Nov. 24
Martin Shkreli was fired as chief executive officer of KaloBios Pharmaceuticals Inc. following his arrest last week on charges of securities fraud.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.